Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Organogenesis Holdings Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ORGO
Nasdaq
2834
https://investors.organogenesis.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Organogenesis Holdings Inc
Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations
- May 12th, 2024 2:05 pm
Organogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ...
- May 10th, 2024 7:09 pm
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call Transcript
- May 10th, 2024 4:07 pm
Q1 2024 Organogenesis Holdings Inc Earnings Call
- May 10th, 2024 3:49 pm
Organogenesis (ORGO) Q1 2024 Earnings Call Transcript
- May 10th, 2024 12:45 am
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
- May 9th, 2024 8:05 pm
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNuĀ® for Knee Osteoarthritis
- May 2nd, 2024 11:00 am
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
- Apr 16th, 2024 11:30 am
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
- Apr 3rd, 2024 11:30 am
Organogenesis Holdings Full Year 2023 Earnings: Misses Expectations
- Mar 2nd, 2024 2:39 pm
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript
- Mar 2nd, 2024 1:39 pm
Why Organogenesis Holding Stock Plummeted by 18% Today
- Mar 1st, 2024 11:29 pm
Organogenesis (ORGO) Reports Break-Even Earnings for Q4
- Feb 29th, 2024 10:45 pm
Organogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024
- Feb 29th, 2024 9:38 pm
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
- Feb 29th, 2024 9:05 pm
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
- Feb 12th, 2024 12:30 pm
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
- Feb 8th, 2024 9:05 pm
Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice
- Jan 15th, 2024 5:00 pm
Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested five years ago
- Jan 14th, 2024 12:11 pm
Best Momentum Stocks to Buy for January 5th
- Jan 5th, 2024 3:00 pm
Scroll